Answers are grounded in this paper and cite their sources.
Obesity is strongly associated with metabolic dysfunction, including insulin resistance and lipid dysregulation. A central mediator of obesity induced metabolic syndrome is reduced adipogenesis, or loss of the ability of adipose derived stem cells (ADSCs) to differentiate into mature lipid storing adipocytes, leading to hypertrophy and dysfunction of existing adipocytes. We previously demonstrated that adipocyte-specific deletion of the endothelin-1 type B receptor (ETB) (adETBKO) increases plasma adiponectin, an insulin sensitizing protein produced by adipocytes, and enhances adipose expression of the master adipogenic regulator PPARγ in high fat diet (HFD)–fed mice. This was associated with a 10% reduction in adipocyte size in visceral adipose, implicating ETB signaling in adipogenesis and adipocyte dysfunction; however, the role of ET-1/ETB signaling in adipogenesis remains unclear. We hypothesized that ET-1, acting through ETB receptor, inhibits ADSC lineage commitment and maturation to adipocytes, leading to adipose hypertrophy in obesity. To test this, primary ADSCs were isolated from subcutaneous adipose of control mice and treated with vehicle or ET-1 (100 nM) during the differentiation process that was carried out using a standard adipogenic cocktail. ET-1 exposure during differentiation significantly reduced adiponectin secretion and suppressed adipogenesis evidenced by reduced Oil Red O staining by ~40% following maturation. These effects were rescued by the ETB antagonist BQ788, confirming ETB-dependent inhibition of adipogenesis by ADSCs. In addition, chronic ET-1 treated adipocytes showed hypertrophy indicated by increased lipid content and droplet size following 5 days of maturation. Together, these data demonstrate that ET-1/ETB signaling exerts an inhibitory effect on adipocyte formation and contributes to maladaptive adipose remodeling. These data suggest ETB receptor blockade as a potential therapeutic to restore adipose tissue function and improve metabolic heath in obesity. This abstract was presented at the American Physiology Summit 2026 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.
No takes yet. Share an insight, caveat, or question.
KONADU et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: